|  | |  |  | PD 312237 Basic information | 
 | Product Name: | PD 312237 |  | Synonyms: | PD 312237;(4R)-1-[[2,3-dihydroxy-5-(hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl]-4-(2-methylpropyl)pyrrolidin-2-one;Pregabalin Impurity 20(PD 312237);PD 312237(Discontinued, see P217850);(4R)-1-((2,3-Dihydroxy-5-(hydroxymethyl)-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-2-yl)methyl)-4-isobutylpyrrolidin-2-one;Pregabalin impurityPD312237;Pregabalin Impurity 20(PD0312237) |  | CAS: | 501666-23-5 |  | MF: | C20H35NO11 |  | MW: | 465.492 |  | EINECS: |  |  | Product Categories: | Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemicals |  | Mol File: | 501666-23-5.mol |  |  | 
|  |  | PD 312237 Chemical Properties | 
|  |  | PD 312237 Usage And Synthesis | 
 | Uses | PD 312237 is a furanoside lactose conjugate degradation product of pregabalin (P704800), a GABA analogue used as an anticonvulsant. | 
|  |  | PD 312237 Preparation Products And Raw materials | 
 |